Trials / Completed
CompletedNCT04150133
Effects and Tolerability With Clenpiq and Low Residue Diet
The Effects and Tolerability of a Prescribed Low Residue Diet the Day Before Colonoscopy on the Cleanliness of the Colon vs. the Traditional Clear Liquid, Day Before Diet With the Use of the Clenpiq Bowel Purgative
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 154 (actual)
- Sponsor
- Hillmont GI · Academic / Other
- Sex
- All
- Age
- 18 Years – 80 Years
- Healthy volunteers
- Accepted
Summary
The Efficacy of Clenpiq utilized per FDA labeling, with a low residue diet the day before colonoscopy.
Detailed description
This study proposes to assess the use of a low residue diet of a prescribed nature the day before colonoscopy for breakfast, lunch and early dinner. Clinical outcomes utilizing the low residue diet will be compared to the Food and Drug Administration (FDA) approved split dose labeling, including the traditional clear liquid diet the day before colonoscopy utilizing the Clenpiq (Ferring Pharmaceuticals) bowel preparation.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| OTHER | Low Residue Diet | Variable cohort will eat 3 low residue meals on the day prior to their planned colonoscopy |
Timeline
- Start date
- 2019-11-21
- Primary completion
- 2021-01-01
- Completion
- 2021-10-01
- First posted
- 2019-11-04
- Last updated
- 2022-03-16
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT04150133. Inclusion in this directory is not an endorsement.